2020
Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck
Jacobs D, Olino K, Park HS, Clune J, Cheraghlou S, Girardi M, Burtness B, Kluger H, Judson BL. Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck. Otolaryngology 2020, 164: 1214-1221. PMID: 33079010, DOI: 10.1177/0194599820967001.Peer-Reviewed Original ResearchConceptsNode-negative Merkel cell carcinomaLymph node evaluationImproved overall survivalPrimary tumor excisionMerkel cell carcinomaCase volumeOverall survivalSurgical managementCell carcinomaTumor excisionTreatment selectionNode evaluationCox proportional hazards regressionGuideline-recommended carePrimary treatment selectionNational Cancer DatabaseNode-negative diseasePercentage of patientsRetrospective cohort analysisInitial surgical managementKaplan-Meier analysisWide local excisionProportional hazards regressionRates of receiptInitial management
2019
The impact of facility characteristics on Merkel cell carcinoma outcomes: A retrospective cohort study
Cheraghlou S, Agogo GO, Girardi M. The impact of facility characteristics on Merkel cell carcinoma outcomes: A retrospective cohort study. Journal Of The American Academy Of Dermatology 2019, 89: 70-80. PMID: 31473294, DOI: 10.1016/j.jaad.2019.08.058.Peer-Reviewed Original ResearchConceptsMerkel cell carcinomaPropensity score-matched cohortDisease-specific survivalPatient survivalCase volumeRare neuroendocrine skin cancerTreatment of MCCVolume facilitiesFacility characteristicsLocal recurrence dataNational Cancer DatabaseRetrospective cohort studyRetrospective cohort analysisHigh-volume centersNeuroendocrine skin cancerAcademic affiliationFacility-level characteristicsMCC outcomesCohort studyExperienced centersRare malignancyNonacademic facilitiesCell carcinomaCancer DatabaseCohort analysis
2018
Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival
Cheraghlou S, Agogo GO, Girardi M. Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival. Journal Of The American Academy Of Dermatology 2018, 80: 979-989. PMID: 30365997, DOI: 10.1016/j.jaad.2018.10.026.Peer-Reviewed Original ResearchConceptsLong-term patient survivalImproved long-term patient survivalHigh-volume centersPatient survivalCase volumeNonmetastatic melanomasPatient outcomesTop quartileMiddle quartilesLong-term patient outcomesHigh-volume academic centersCenter case volumeFacility case volumeTreatment center characteristicsDisease-specific survivalNational Cancer DatabaseHigh-volume facilitiesCases of melanomaAcademic affiliationImproved survivalCancer careCancer DatabaseImproved outcomesUS adultsAcademic centers